Buspirone Hydrochloride Tablet
Product Images NDC 51655-097

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 51655-097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg Third (10mg One Third)

FDA Label Image

10mg Two Thirds (10mg Two Thirds)

FDA Label Image

15mg Half (15mg Half)

FDA Label Image

15mg Split (15mg Splitting)

FDA Label Image

15mg (15mg Whole)

FDA Label Image

20mg Two Thirds (20mg Two Thirds)

FDA Label Image

30mg Split (30mg Splitting)

FDA Label Image

30mg Whole (30mg Whole)

FDA Label Image

Label (51655 097 83 Rev A 12 22)

This is a description of BusPIRone Hydrochloride Tablets, USP 10mg, with 180 tablets. This medication is only available by prescription and should be stored at 20°-25°C (68°-77°F). It is important to keep this medication out of the reach of children and store it in a cool, dry place. Each tablet contains Buspione and Hydrochloride, USP 10mg. The manufacturer is Avet Pharmaceutical Inc., Lot 0000000000.*

FDA Label Image

5mg One Third (5mg One Third)

FDA Label Image

7.5mg Half (7 5mg Half)

FDA Label Image

Logo 1 (Avet Logo)

FDA Label Image

Chemical-structure-buspirone (Chemical Structure Buspirone)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.